Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Shares Drop Nearly 10 Percent

Shares of Third Wave Technologies fell nearly 10 percent for the five-day trading week ended Tuesday. The only news to come from the firm was last week’s announcement that its Japanese subsidiary had raised roughly $5.3 million in a Series A financing. The stock led all decliners in the BCW Index for the week.
 
Bruker BioSciences' stock rose 5 percent, leading the six stocks that gained value during the tracking period.
 
Stratagene was removed from the Index after Agilent Technologies completed the acquisition of the firm last week.
 
Overall, the Index lost .9 percent, while the Dow Jones Industrial Average fell 2.2 percent, the Nasdaq declined 2.4 percent, and the Nasdaq Biotech Index lost 3.3 percent.

 
 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Closing Price
(June 12, 2007)
Starting Price
(
June 5, 2007)
% change
Affymetrix
AFFX
24.69
26.17
-5.66
Agilent
A
37.47
38.47
-2.60
Applied Biosystems
ABI
28.48
28.92
-1.52
Beckman
BEC
67.16
66.26
1.36
Becton Dickinson
BDX
74.44
75.54
-1.46
Bio-Rad
BIO
73.68
74.13
-0.61
Bruker
BRKR
9.15
8.71
5.05
Caliper
CALP
4.21
4.25
-0.94
Cepheid
CPHD
11.36
11.87
-4.30
Illumina
ILMN
36.96
35.51
4.08
Invitrogen
IVGN
73.82
73.64
0.24
Luminex
LMNX
11.92
12.20
-2.30
MDS
MDZ
19.72
20.51
-3.85
Millipore
MIL
74.44
74.77
-0.44
PerkinElmer
PKI
26.36
26.68
-1.20
Qiagen
QGEN
16.65
16.57
0.48
Sequenom
SQNM
4.7
4.79
-1.88
Sigma-Aldrich
SIAL
41.12
43.01
-4.39
Thermo
TMO
51.44
53.17
-3.25
Third Wave
TWTI
5.54
6.13
-9.62
Waters
WAT
60.53
59.61
1.54
BCW Index Average  
35.90
35.08
-0.93
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.